Live Breaking News & Updates on Chronic Cluster Headaches

Stay updated with breaking news from Chronic cluster headaches. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

This Biotech Is Entering The Clinical Stage With A Psilocin Analog Targeting Cluster Headaches - Lobe Sciences (OTC:LOBEF)

Lobe Sciences Ltd. (OTCQB: LOBEF), a biopharmaceutical company focused on non-hallucinatory doses of stabilized psychedelic-based compounds to treat rare diseases, has commenced its Phase 1 clinical study on proprietary psilocin analog L-130.  ....

Lobeceo Philip Young , Lobe Sciences Ltd , Drug Administration , Lobe Sciences , Chronic Cluster Headaches ,